Efficacy of Certolizumab Pegol for Psoriasis of the Head and Neck in Two Phase 3 Clinical Trials: CIMPASI-1 and CIMPASI-2

Main Article Content

P van de Kerkhof
A Pinter
M Boehnlein
S Kavanagh
J.J. Crowley

Keywords

psoriasis, certolizumab, head, neck

Abstract

Abstract not available.

References

1. WHO Global Report on Psoriasis. Available at: https://apps.who.int/iris/handle/10665/204417.
.
2. Merola JF. et al. Dermatol Ther 2018;e12589.

3. Timotijević ZS. et al. Acta Dermatovenerol Croat. 2017;25:215–22.

4. Certolizumab Pegol Prescribing Information. Available at www.fda.gov/drugs.

5. Certolizumab Pegol Summary of Product Characteristics. Available at www.ema.europa.eu/ema.

6. Gottlieb AB. et al. JAAD. 2018;79:302–14.e6.

7. Thaçi D. et al. Acta Derm Venereol. 2018;98, Supp No. 219.